Observational studyCurrent medical science2018

Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics.

Ji-Hao Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.